Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
D000293:Adolescent; D002614:Chelating Agents / Q000627:therapeutic use*; D002712:Chlorides; D003300:Copper / Q000378:metabolism; D005029:Ethylenediamines / Q000627:therapeutic use*; D006527:Hepatolenticular Degeneration / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced*; D009461:Neurologic Manifestations; D010396:Penicillamine / Q000009:adverse effects*
D002614:Chelating Agents; D002712:Chlorides; D005029:Ethylenediamines; D003300:Copper; D010396:Penicillamine